AON
47
-9
AMT
45
-5
HBAN
47
2
BK
46
3
OMC
28
-11
V
40
14
TEL
40
4
ES
4
-7
EXPD
21
-2
DUK
49
-3
PAYX
29
-6
AZO
45
-7
BSX
55
2
GWW
41
-3
URBN
40
-2
PH
48
6
PHM
41
-5
ZION
49
4
MET
47
2
MNST
55
3
AON
47
-9
AMT
45
-5
HBAN
47
2
BK
46
3
OMC
28
-11
V
40
14
TEL
40
4
ES
4
-7
EXPD
21
-2
DUK
49
-3
PAYX
29
-6
AZO
45
-7
BSX
55
2
GWW
41
-3
URBN
40
-2
PH
48
6
PHM
41
-5
ZION
49
4
MET
47
2
MNST
55
3
Financhill
Back

Bicara Therapeutics Vs. SpringWorks Therapeutics Industry Stock Comparison

Sell
1

BCAX
Bicara Therapeutics

Last Price:
$9.52
Seasonality Move:
--
Sell
11

SWTX
SpringWorks Therapeutics

Last Price:
$36.97
Seasonality Move:
5.59%
Sell
1
Bicara Therapeutics (BCAX) is a Sell

Is Bicara Therapeutics a Buy, Sell or Hold?

  • The current Bicara Therapeutics [BCAX] share price is $9.51. The Score for BCAX is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • BCAX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
11
SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics a Buy, Sell or Hold?

  • The current SpringWorks Therapeutics [SWTX] share price is $36.99. The Score for SWTX is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
  • SWTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BCAX Stock Price Chart

What is Bicara Therapeutics's stock price today?

  • The Bicara Therapeutics share price today is $9.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing slight selling pressure.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

  • The SpringWorks Therapeutics share price today is $36.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing slight selling pressure.

BCAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.6 Sell
Relative Strength Index (14 RSI): 31.11 Sell
Chaikin Money Flow: -177722 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.78 - 14.54) Sell
Bollinger Bands (100): (12 - 18.98) Sell

SWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.41 Sell
Relative Strength Index (14 RSI): 31.76 Sell
Chaikin Money Flow: -1228444 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.93 - 51.91) Sell
Bollinger Bands (100): (35.17 - 50.17) Sell

BCAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.21 Sell
20-day SMA: 12.78 Sell
50-day SMA: 12.9 Sell
200-day SMA: 0 Buy
8-day EMA: 11.71 Sell
20-day EMA: 12.55 Sell
50-day EMA: 13.33 Sell
200-day EMA: 11.35 Sell

SWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.32 Sell
20-day SMA: 47.1 Sell
50-day SMA: 47.64 Sell
200-day SMA: 39.14 Sell
8-day EMA: 42.51 Sell
20-day EMA: 45.83 Sell
50-day EMA: 46.19 Sell
200-day EMA: 41.19 Sell

Bicara Therapeutics Earnings Growth & BCAX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and a decrease next year of $0.51 per share.

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $2.06 per share.

Bicara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

SpringWorks Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):